Holen Sie sich die Stockscreener-App
0.171
1.16%
-0.002
Handel nachbörslich:
.17
-0.001
-0.58%
Schlusskurs vom Vortag:
$0.173
Offen:
$0.1755
24-Stunden-Volumen:
1.06M
Relative Volume:
0.08
Marktkapitalisierung:
$2.15M
Einnahmen:
$24,000
Nettoeinkommen (Verlust:
$-78.06M
KGV:
-0.0059
EPS:
-28.9956
Netto-Cashflow:
$-21.81M
1W Leistung:
+8.92%
1M Leistung:
-29.22%
6M Leistung:
-54.40%
1J Leistung:
-89.00%
1-Tages-Spanne:
$0.165
$0.1793
1-Wochen-Bereich:
$0.146
$0.20
52-Wochen-Spanne:
$0.146
$2.49
Catheter Precision Inc. Stock (VTAK) Company Profile
Firmenname
Catheter Precision Inc.
Sektor
Branche
Telefon
973 691 2000
Adresse
1670 Highway 160 West, Suite 205, Fort Mill
Vergleichen Sie VTAK mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VTAK
Catheter Precision Inc.
|
0.171 | 4.14M | 24,000 | -78.06M | -21.81M | -29.00 |
|
ABT
Abbott Laboratories
|
129.40 | 228.03B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.50 | 152.09B | 18.49B | 2.51B | 3.23B | 1.68 |
|
SYK
Stryker Corp
|
378.95 | 143.98B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.91 | 117.98B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.68 | 45.17B | 5.69B | 4.14B | 577.90M | 6.96 |
Catheter Precision Inc. Stock (VTAK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2019-08-13 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2018-11-02 | Eingeleitet | Maxim Group | Buy |
Catheter Precision Inc. Aktie (VTAK) Neueste Nachrichten
Price Consolidation Hints at Upcoming Move in Catheter Precision Inc.Watch List & Low Risk Investment Opportunities - 선데이타임즈
Real Time Chart Alerts Flash Bullish on Catheter Precision Inc.2025 Analyst Calls & Risk Managed Trade Strategies - 선데이타임즈
Catheter Precision's LockeT device shows versatility in first German hospital procedures - Stock Titan
Best data tools to analyze Catheter Precision Inc. stockMarket Growth Review & Community Consensus Trade Signals - Newser
Has Catheter Precision Inc. found a price floor2025 Winners & Losers & Fast Exit and Entry Strategy Plans - Newser
Catheter Precision Inc. stock trend outlook and recovery pathMarket Sentiment Report & Free Low Drawdown Momentum Trade Ideas - Newser
Technical analysis overview for Catheter Precision Inc. stock [2025 Performance Recap]Reliable Price Action Trade Plans - Newser
Forecasting Catheter Precision Inc. price range with options dataShort-Term Swing Opportunity Summary Sheet - Newser
Can momentum traders help lift Catheter Precision Inc.Predictable Entry Strategy With Technical Backing - Newser
Volume Profile Shows Strong Base for Catheter Precision Inc.Real-Time Trade Insights Spark Market Reactions - 선데이타임즈
Short interest data insights for Catheter Precision Inc.Equity Market Return Forecast Model Update - Newser
Catheter Precision net loss hits USD 5.4 million in Q2 2025 - Medical Buyer
Comparing Catheter Precision Inc. in custom built stock radarsLong-Term Stock Growth Forecast Insights - Newser
Technical analysis overview for Catheter Precision Inc. stockFree Accurate Technical Trend Reversal Picks - Newser
Using Python tools to backtest Catheter Precision Inc. strategiesSmart Safety Strategy With Real Data Analysis - Newser
Technical signs of recovery in Catheter Precision Inc.Free Trade Ready Stock Watch for Short Term - Newser
Catheter Precision Q2 revenue up 128% YoY, 48% QoQ. - AInvest
Catheter Precision Reports 128% Year-Over-Year Revenue Growth in Q2, Advances Clinical and Strategic Initiatives - Barchart.com
Catheter Precision, Inc. Reports Results of Operations for Second Quarter 2025 - The Manila Times
Catheter Precision Reports Massive 128% Revenue Growth as New Heart Device Gets European Approval - Stock Titan
Why Catheter Precision Inc. stock attracts strong analyst attentionChart Pattern Recognition for Profit Timing - Newser
How Catheter Precision Inc. stock performs during market volatilityShort-Term Sector Movement Forecast Generator - Newser
Published on: 2025-08-11 01:05:33 - Newser
Is this a good reentry point in Catheter Precision Inc.AI Enhanced Strategy for Portfolio Growth - Newser
Tools to monitor Catheter Precision Inc. recovery probabilityWeekly Hot Stocks Based on Volume Flow - Newser
Will Catheter Precision Inc. stock go up soonAutomated AI Forecast with Trading Alerts - Newser
Will Catheter Precision Inc. Stock Benefit from AI and Green Energy TrendsFree Optimized Watchlist With Daily Adjustments - Newser
Is Catheter Precision Inc. Forming a Consolidation BaseSwing Setup With Technical Confirmation Explained - beatles.ru
How Resilient Is Catheter Precision Inc. Stock During Economic DownturnsMomentum Entry Alerts with Risk Control - Newser
Applying sector rotation models to Catheter Precision Inc.Low Volatility Stock Analysis With Confidence - Newser
Milestone Achievement for Hospital Using Catheter Precision’s VIVO System - BioSpace
Milestone Achievement for Hospital Using Catheter Precision's VI - GuruFocus
Heart Hospital of New Mexico completes 200 VIVO procedures for Catheter Precision. - AInvest
Major Milestone: First Hospital Reaches 200 Cardiac Procedures With Revolutionary VIVO Technology - Stock Titan
Has Catheter Precision Inc. Stock Ever Crashed Historical Volatility ReviewProven Trading System with Consistent Gains - Newser
How does Catheter Precision Inc. compare to its industry peersAchieve breakthrough gains with expert advice - Jammu Links News
What are analysts’ price targets for Catheter Precision Inc. in the next 12 monthsInvest in stocks with strong fundamentals - Jammu Links News
What is the risk reward ratio of investing in Catheter Precision Inc. stockSuperior profit margins - Jammu Links News
Catheter Precision (VTAK.A) Surges 11.25% — What’s Behind the Intraday Spike? - AInvest
Is Catheter Precision Inc. a growth stock or a value stockFree Predictions - Jammu Links News
Is Catheter Precision Inc. stock overvalued or undervaluedInvest confidently with real-time updates - Jammu Links News
Finanzdaten der Catheter Precision Inc.-Aktie (VTAK)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.31%
1.36%
Kapitalisierung:
|
Volumen (24h):